SEC Filing Details
Document Details
Form
Filing Date
August 13, 2024
Document Date
June 30, 2024
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.